Join
Live feed
·
INSIDERFilingvia Quantisnow
Lucid Diagnostics Inc. logo

Pavmed Inc. acquired $4,675,474 worth of shares (3,331,771 units at $1.40), increasing direct ownership by 11% to 34,634,191 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LUCD· Lucid Diagnostics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LUCD (Lucid Diagnostics Inc.) and more on Quantisnow.